Book contents
- Essentials of Anesthesia for Infants and Neonates
- Essentials of Anesthesia for Infants and Neonates
- Copyright page
- Contents
- Contributors
- Preface
- Section 1 Newborn and Infant Physiology for Anesthetic Management
- 1 The Term Infant
- 2 The Preterm Infant
- 3 Origin of the NICU
- 4 Hemodynamics in the Infant
- 5 Measures of Carbon Dioxide
- 6 Glucose Control
- 7 Oxygen Management
- 8 Temperature Control
- 9 Neonatal Resuscitation
- 10 Congenital Abnormalities and Syndromes
- 11 Myopathies of the Newborn
- Section 2 Newborn and Infant Anesthesia
- Section 3 Specific Newborn and Infant Procedures
- Section 4 Pain Management and Other Newborn and Infant Anesthesia Concerns
- Index
- References
11 - Myopathies of the Newborn
from Section 1 - Newborn and Infant Physiology for Anesthetic Management
Published online by Cambridge University Press: 09 February 2018
Edited by
Book contents
- Essentials of Anesthesia for Infants and Neonates
- Essentials of Anesthesia for Infants and Neonates
- Copyright page
- Contents
- Contributors
- Preface
- Section 1 Newborn and Infant Physiology for Anesthetic Management
- 1 The Term Infant
- 2 The Preterm Infant
- 3 Origin of the NICU
- 4 Hemodynamics in the Infant
- 5 Measures of Carbon Dioxide
- 6 Glucose Control
- 7 Oxygen Management
- 8 Temperature Control
- 9 Neonatal Resuscitation
- 10 Congenital Abnormalities and Syndromes
- 11 Myopathies of the Newborn
- Section 2 Newborn and Infant Anesthesia
- Section 3 Specific Newborn and Infant Procedures
- Section 4 Pain Management and Other Newborn and Infant Anesthesia Concerns
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Essentials of Anesthesia for Infants and Neonates , pp. 91 - 98Publisher: Cambridge University PressPrint publication year: 2018
References
1.Amburgey, K, McNamara, N, Bennett, LR, et al. Prevalence of congenital myopathies in a representative pediatric United States population. Ann Neurol. 2011;70(4):662–5.Google Scholar
2.Kinder Ross, A. Muscular dystrophy versus mitochondrial myopathy: the dilemma of the undiagnosed hypotonic child. Paediatr Anaesth. 2007;17:1–6.Google Scholar
3.Bonnemann, CG, Wang, CH, Quijano-Roy, S, et al. Diagnostic approach to the congenital muscular dystrophies. Neuromuscul Disord. 2014;24(4):289–311.Google Scholar
4.Bharucha-Goebel, DX, Santi, M, Medne, L, et al. Severe congenital RYR1-associated myopathy: the expanding clinicopathologic and genetic spectrum. Neurology. 2013;80(17):1584–9.Google Scholar
5.Shieh, PB. Muscular dystrophies and other genetic myopathies. Neurol Clin. 2013;31(4):1009–29.Google Scholar
6.Laing, NG. Genetics of neuromuscular disorders. Crit Rev Clin Lab Sci. 2012;49(2):33–48.CrossRefGoogle ScholarPubMed
7.Scrivener, TA, Ross, SM, Street, NE, Webster, RI, De Lima, JC. A case series of general anesthesia in children with laminin alpha2 (merosin)-deficient congenital muscular dystrophy. Paediatr Anaesth. 2014;24(4):464–5.CrossRefGoogle ScholarPubMed
8.Online Mendelian Inheritance in Man. Muscular dystrophy, congenital merosin-deficient, 1A, 2003 Available at: www.omim.org/entry/607855.Google Scholar
9.Online Mendelian Inheritance in Man. Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), Type A, 1, 1986 Available at: www.omim.org/entry/236670.Google Scholar
10.Online Mendelian Inheritance in Man. Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), Type A, 4, 1986. Available at: www.omim.org/entry/253800.Google Scholar
11.Schara, U, Schoser, BG. Myotonic dystrophies type 1 and 2: a summary on current aspects. Semin Pediatr Neurol. 2006;13(2):71–9.CrossRefGoogle ScholarPubMed
12.Mulley, JC, Staples, A, Donnelly, A, et al. Explanation for exclusive maternal origin for congenital form of myotonic dystrophy. Lancet. 1993;341(8839):236–7.Google Scholar
13.Quijano-Roy, S, Mbieleu, B, Bonnemann, CG, et al. De novo LMNA mutations cause a new form of congenital muscular dystrophy. Ann Neurol. 2008;64(2):177–86.Google Scholar
14.Mercuri, E, Poppe, M, Quinlivan, R, et al. Extreme variability of phenotype in patients with an identical missense mutation in the lamin A/C gene: from congenital onset with severe phenotype to milder classic Emery–Dreifuss variant. Arch Neurol. 2004;61(5):690–4.Google Scholar
15.North, KN, Laing, NG, Wallgren-Pettersson, C. Nemaline myopathy: current concepts. The ENMC International Consortium and Nemaline Myopathy. J Med Genet. 1997;34(9):705–13.Google Scholar
16.Jungbluth, H, Sewry, CA, Muntoni, F. Core myopathies. Semin Pediatr Neurol. 2011;18(4):239–49.Google Scholar
17.Klingler, W, Rueffert, H, Lehmann-Horn, F, Girard, T, Hopkins, PM. Core myopathies and risk of malignant hyperthermia. Anesth Analg. 2009;109(4):1167–73.CrossRefGoogle ScholarPubMed
18.Jungbluth, H, Muller, CR, Halliger-Keller, B, et al. Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores. Neurology. 2002;59(2):284–7.CrossRefGoogle Scholar
19.Brislin, RP, Theroux, MC. Core myopathies and malignant hyperthermia susceptibility: a review. Paediatr Anaesth. 2013;23(9):834–41.CrossRefGoogle ScholarPubMed
20.Jungbluth, H, Wallgren-Pettersson, C, Laporte, J. Centronuclear (myotubular) myopathy. Orphanet J Rare Dis. 2008;3:26.Google Scholar
21.MacLeod, MJ, Taylor, JE, Lunt, PW, Mathew, CG, Robb, SA. Prenatal onset spinal muscular atrophy. Eur J Paediatr Neurol. 1999;3(2):65–72.Google Scholar
22.D’Amico, A, Mercuri, E, Tiziano, FD, Bertini, E. Spinal muscular atrophy. Orphanet J Rare Dis. 2011;6:71.CrossRefGoogle ScholarPubMed
23.Islander, G. Anesthesia and spinal muscle atrophy. Paediatr Anaesth. 2013;23(9):804–16.CrossRefGoogle ScholarPubMed
24.Papazian, O. Transient neonatal myasthenia gravis. J Child Neurol. 1992;7(2):135–41.CrossRefGoogle ScholarPubMed
25.Dimauro, S, Garone, C. Metabolic disorders of fetal life: glycogenoses and mitochondrial defects of the mitochondrial respiratory chain. Semin Fetal Neonatal Med. 2011;16(4):181–9.Google Scholar
26.Niezgoda, J, Morgan, PG. Anesthetic considerations in patients with mitochondrial defects. Paediatr Anaesth. 2013;23(9):785–93.Google Scholar
27.von Kleist-Retzow, JC, Cormier-Daire, V, Viot, G, et al. Antenatal manifestations of mitochondrial respiratory chain deficiency. J Pediatr. 2003;143(2):208–12.CrossRefGoogle ScholarPubMed
28.Gibson, K, Halliday, JL, Kirby, DM, et al. Mitochondrial oxidative phosphorylation disorders presenting in neonates: clinical manifestations and enzymatic and molecular diagnoses. Pediatrics. 2008;122(5):1003–8.CrossRefGoogle ScholarPubMed
29.Uziel, G, Ghezzi, D, Zeviani, M. Infantile mitochondrial encephalopathy. Semin Fetal Neonatal Med. 2011;16(4):205–15.Google Scholar
30.Fassone, E, Rahman, S. Complex I deficiency: clinical features, biochemistry and molecular genetics. J Med Genet. 2014;49:578–90.Google Scholar
31.Distelmaier, F, Koopman, WJ, van den Heuvel, LP, et al. Mitochondrial complex I deficiency: from organelle dysfunction to clinical disease. Brain. 2009;132(Pt 4):833–42.Google ScholarPubMed
32.Jakobs, BS, van den Heuvel, LP, Smeets, RJ, et al. A novel mutation in COQ2 leading to fatal infantile multisystem disease. J Neurol Sci. 2013;326(1–2):24–8.Google Scholar
33.Falk, MJ, Polyak, E, Zhang, Z, et al. Probucol ameliorates renal and metabolic sequelae of primary CoQ deficiency in Pdss2 mutant mice. EMBO Mol Med. 2011;3(7):410–27.CrossRefGoogle ScholarPubMed
34.Fricker, RM, Raffelsberger, T, Rauch-Shorny, S, et al. Positive malignant hyperthermia susceptibility in vitro test in a patient with mitochondrial myopathy and myoadenylate deaminase deficiency. Anesthesiol. 2002;97(6):1635–7.Google Scholar
35.Keyes, MA, Van de Wiele, BV, Stead, SW. Mitochondrial myopathies: an unusual cause of hypotonia in infants and children. Paediatr Anaesth. 1996;6(4):329–35.Google Scholar
36.Brandom, BW, Veyckemans, F. Neuromuscular diseases in children: a practical approach. Paediatr Anaesth. 2013;23(9):765–9.CrossRefGoogle ScholarPubMed